InvestorsHub Logo
Followers 1
Posts 54
Boards Moderated 0
Alias Born 05/08/2013

Re: None

Thursday, 10/15/2015 12:29:19 PM

Thursday, October 15, 2015 12:29:19 PM

Post# of 772
Chartists like VTL, but news supports it.

The new trial protocol has been submitted to the FDA. 35 sites are in the process of being set up in the U.S and Europe. Now that the news has spread, VTL is heading back to the $12 to $18 area that it had in the latter stages of the prior trial. I don't see it pushing 30 again until we get the first positive result. Options players believe this is going to $10 by tomorrow (options expiration). Don't know that it will move that fast, but fair value right now is about $12, with a move toward the $15-$18 range as the 4th quarter goes on, as we will be much closer to the first subject being enrolled. This stock will fly on any positive data! Happy to be in this. Good luck to all longs